What is United Therapeutics's u.s. — total revenues?

United Therapeutics (UTHR) reported u.s. — total revenues of $744.20M in Q1 2026.

How has United Therapeutics's u.s. — total revenues changed year-over-year?

United Therapeutics's u.s. — total revenues decreased by 0.7% year-over-year, from $749.60M to $744.20M.

What is the long-term trend for United Therapeutics's u.s. — total revenues?

Over 4 years (2021 to 2025), United Therapeutics's u.s. — total revenues has grown at a 18.0% compound annual growth rate (CAGR), from $1.56B to $3.04B.

Geographic · Total revenues

U.S. — Total revenues

United Therapeutics U.S. — Total revenues decreased by 1.1% to $744.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.7%, from $749.60M to $744.20M. Over 4 years (FY 2021 to FY 2025), U.S. — Total revenues shows an upward trend with a 18.0% CAGR.

Analysis

StatementSegment

First reportedQ1 2017

Last reportedQ1 2026May 6, 2026

Rolls up toTotal Revenue

Metric ID: uthr_segment_u_s_total_revenues

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$411.70M	$412.10M	$386.10M	$409.80M	$440.40M	$500.20M	$463.70M	$469.70M	$562.00M	$584.60M	$585.90M	$641.50M	$675.20M	$717.30M	$705.70M	$749.60M	$759.80M	$774.80M	$752.80M	$744.20M
QoQ Change	—	+0.1%	-6.3%	+6.1%	+7.5%	+13.6%	-7.3%	+1.3%	+19.7%	+4.0%	+0.2%	+9.5%	+5.3%	+6.2%	-1.6%	+6.2%	+1.4%	+2.0%	-2.8%	-1.1%
YoY Change	—	—	—	—	+7.0%	+21.4%	+20.1%	+14.6%	+27.6%	+16.9%	+26.4%	+36.6%	+20.1%	+22.7%	+20.4%	+16.9%	+12.5%	+8.0%	+6.7%	-0.7%

Range$386.10M – $774.80M

CAGR+13.3%

Avg YoY Growth+17.3%

Median YoY Growth+18.5%

Current Streak2 quarters decline

Frequently Asked Questions

What is United Therapeutics's u.s. — total revenues?: United Therapeutics (UTHR) reported u.s. — total revenues of $744.20M in Q1 2026.
How has United Therapeutics's u.s. — total revenues changed year-over-year?: United Therapeutics's u.s. — total revenues decreased by 0.7% year-over-year, from $749.60M to $744.20M.
What is the long-term trend for United Therapeutics's u.s. — total revenues?: Over 4 years (2021 to 2025), United Therapeutics's u.s. — total revenues has grown at a 18.0% compound annual growth rate (CAGR), from $1.56B to $3.04B.